The role of CXC chemokine ligand (CXCL)12-CXC chemokine receptor (CXCR)4 signalling in the migration of neural stem cells towards a brain tumour

Neuropathology and Applied Neurobiology

Volumn 35, Issue 6, 2009, Pages 579-591

  Van Der Meulen, A A E ^a   Biber, K ^a   Lukovac, S ^a   Balasubramaniyan, V ^a   Den Dunnen, W F A ^a   Boddeke, H W G M ^a   Mooij, J J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Brain tumours; CXCL12; CXCR4; Melanoma; Migration; Neural stem cells; SDF 1a

Indexed keywords

CALCIUM; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL MEMBRANE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; HEMISPHERE; ISOGRAFT; MELANOMA; METASTASIS; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBVENTRICULAR ZONE; TUMOR CELL; TUMOR MODEL;

ADULT STEM CELLS; ANIMALS; BRAIN NEOPLASMS; CALCIUM; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; CHEMOTAXIS; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NEURONS; RECEPTORS, CXCR; RECEPTORS, CXCR4; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEM CELL NICHE;

EID: 70449697977     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2009.01036.x     Document Type: Article

References (48)

1. Saha S, Meyer M, Krementz ET, Hoda S, Carter RD, Muchmore J, Sutherland C. Prognostic evaluation of intracranial metastasis in malignant melanoma. Ann Surg Oncol 1994 1 : 38 44
2. Sampson JH, Carter JH, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998 1 : 11 20
3. Aboody KS, Brown AB, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 2000 23 : 12846 12851
4. Tang Y, Shah K, Messerli SM, Snyder EY, Breakefield XO, Weissleder R. In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther 2003 13 : 1247 1254
5. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004 52 : 18117 18122
6. Burns MJ, Weiss W. Targeted therapy of brain tumours utilizing neural stem and progenitor cells. Front Biosci 2003 8 : e228 34
7. Ehtesham M, Yuan X, Kabos P, Chung NH, Liu G, Akasaki Y, Black KL, Yu JS. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004 3 : 287 293
8. Aboody KS, Najbauer J, Schmidt NO, Yang W, Wu JK, Zhuge Y, Przylecki W, Carroll R, Black PM, Perides G. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol 2006 2 : 119 126
9. Lynch WP, Sharpe AH, Snyder EY. Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. J Virol 1999 8 : 6841 6851
10. Herrlinger U, Woiciechowski C, Sena-Esteves M, Aboody KS, Jacobs AH, Rainov NG, Snyder EY, Breakefield XO. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther 2000 4 : 347 357
11. Uhl M, Weiler M, Wick W, Jacobs AH, Weller M, Herrlinger U. Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. Biochem Biophys Res Commun 2005 1 : 125 129
12. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, Yu JS. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumour necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002 24 : 7170 7174
13. Shah K, Tang Y, Breakefield XO, Weissleder R. Real-time imaging of TRAIL-induced apoptosis of glioma tumours in vivo. Oncogene 2003 44 : 6865 6872
14. Yang SY, Liu H, Zhang JN. Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12. DNA Cell Biol 2004 6 : 381 389
15. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002 20 : 5657 5663
16. Tran PB, Ren DJ, Veldhouse TJ, Miller RJ. Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J Neurosci Res 2004 1 : 20 34
17. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004 3 : 233 245
18. Rollins BJ. Chemokines. Blood 1997 3 : 909 928
19. Wells TN, Power CA, Proudfoot AE. Definition, function and pathophysiological significance of chemokine receptors. Trends Pharmacol Sci 1998 9 : 376 380
20. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000 18 : 217 242
21. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miler LH, Oppenheim JJ, Power CA. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000 1 : 145 176
22. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000 2 : 121 127
23. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001 2 : 108 115
24. Sallusto F, Mackay CR. Chemoattractants and their receptors in homeostasis and inflammation. Curr Opin Immunol 2004 6 : 724 731
25. Luo Y, Cai J, Xue H, Miura T, Rao MS. Functional SDF1 alpha/CXCR4 signaling in the developing spinal cord. J Neurochem 2005 2 : 452 462
26. Reiss K, Mentlein R, Sievers J, Hartmann D. Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer. Neuroscience 2002 1 : 295 305
27. Tran PB, Miller RJ. Chemokine receptors: signposts to brain development and disease. Nat Rev Neurosci 2003 6 : 444 455
28. Biber K, Zuurman MW, Dijkstra IM, Boddeke HWGM. Chemokines in the brain: neuroimmunology and beyond. Curr Opin Pharmacol 2002 1 : 63 8
29. de Jong EK, Dijkstra IM, Hensens M, Brouwer N, van Amerongen M, Liem RS, Boddeke HWGM, Biber K. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J Neurosci 2005 33 : 7548 7557
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 1 : 156 159
31. Biber K, Klotz KN, Berger M. Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci 1997 13 : 4956 4964
32. Biber K, Sauter A, Brouwer N, Copray SC, Boddeke HWGM. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia 2001 2 : 121 133
33. Buffo A, Vosko MR, Erturk D, Hamann GF, Jucker M, Rowitch D, Gotz M. Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair. Proc Natl Acad Sci U S A 2005 50 : 18183 18188
34. Harting MT, Baumgartner JE, Worth LL, Ewing-Cobbs L, Gee AP, Day MC, Cox CS Jr. Cell therapies for traumatic brain injury. Neurosurg Focus 2008 3-4 : E17
35. Zhang SC, Fedoroff S. Expression of stem cell factor and c-kit receptor in neural cells after brain injury. Acta Neuropathol 1999 4 : 393 398
36. de Jong EK, Vinet J, Stanulovic VS, Meijer M, Wesseling E, Sjollema K, Boddeke HWGM, Biber K. Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles. FASEB J 2008 22 : 4136 4145
37. Oh SB, Endoh T, Simen AA, Ren D, Miller RJ. Regulation of calcium currents by chemokines and their receptors. J Neuroimmunol 2002 1-2 : 66 75
38. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 1998 24 : 14500 14505
39. Yip S, Aboody KS, Burns M, Imitola J, Boockvar JA, Allport J, Park KI, Teng YD, Lachyankar M, McIntosh T, O'Rourke DM, Khoury S, Weissleder R, Black PM, Weiss W, Snyder EY. Neural stem cell biology may be well suited for improving brain tumour therapies. Cancer J 2003 3 : 189 204
40. Opdenakker G, van Damme J. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines. Int J Dev Biol 2004 5-6 : 519 527
41. Salmaggi A, Gelati M, Pollo B, Frigerio B, Eoli M, Silvani A, Broggi G, Ciusani E, Croci D. Boiardi A, De Rossi M. CXCL12 in malignant glial tumours: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol 2004 3 : 305 317
42. Rempel SA, Dudas S, Ge S, Gutierrez JA. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000 1 : 102 111
43. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, Masel J, Yenari MA, Weissman IL, Uchida N, Palmer T, Steinberg GK. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 2004 32 : 11839 11844
44. Miller JT, Bartley JH, Wimborne HJ, Walker AL, Hess DC, Hill WD, Carroll JE. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci 2005 6 : 63 74
45. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumour pathogenesis. Am J Physiol Cell Physiol 2007 3 : C987 95
46. Vianello F, Papeta N, Chen T, Kraft P, White N, Hart WK, Kircher MF, Swart E, Rhee S, Palu G, Irimia D, Toner M, Weissleder R, Poznansky MC. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. J Immunol 2006 176 : 2902 2914
47. Brown AB, Yang W, Schmidt NO, Carroll R, Leishear KK, Rainov NG, Black PM, Breakefield XO, Aboody KS. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumours of neural and non-neural origin. Hum Gene Ther 2003 18 : 1777 1785
48. Li M, Ransohoff RM. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 2008 2 : 116 131